Self-monitoring of blood glucose: What are healthcare professionals recommending?

Canadian Journal of Diabetes

Volumn 35, Issue 1, 2011, Pages 31-38

  Latter, Celeste ^a   McLean Veysey, Pam ^b   Dunbar, Peggy ^c   Frail, Dawn ^d   Sketris, Ingrid ^a   Putnam, Wayne ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Pharmacy Department   (Canada)

^c Diabetes Care Program of Nova Scotia   (Canada)

^d Pharmaceutical Services   (Canada)

Author keywords

Blood glucose control; Self monitoring of blood glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; CANADA; CLINICAL PRACTICE; DIABETES EDUCATOR; DIABETES MELLITUS; DIABETIC DIET; GENERAL PRACTITIONER; HEALTH BELIEF; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RESOURCE ALLOCATION; THEMATIC ANALYSIS;

EID: 79955131616     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(11)51006-8     Document Type: Article

References (23)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
2. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S152.
3. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33(suppl 1):S1-S61.
4. O'Kane MJ, Bunting B, Copeland M, et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336:1174-1177.
5. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132.
6. Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2009. http://www.cadth.ca/media/ pdf/C1109_bgts_summary_report_e.pdf. Accessed January 25, 2011.
7. Sanyal C, Graham SD, Cooke C, et al. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada. BMC Health Serv Res. 2008;8:111.
8. Simon J, Gray A, Clarke P, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ. 2008;336:1177-1180.
9. Cameron C, Coyle D, Ur E, et al. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ. 2010;182:28-34.
10. Borden N. Utilization of blood glucose monitoring strips (Nova Scotia Pharmacare Programs). Presented at: Diabetes Care Program of Nova Scotia Workshop; January 22, 2010; Halifax, NS.
11. Patel H, Srishanmuganathan J, Car J, et al. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004. J Public Health (Oxf). 2006;29:48-52.
12. Chaplin S. Excessive spending on self-monitoring blood glucose in T2D. Prescriber. 2009;20:51-52.
13. Belsey JD, Pittard JB, Rao S, et al. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care. Int J Clin Pract. 2009;63:439-448.
14. Patel AD, Kharlamb V, Reiter AP, et al. Self-monitoring of blood glucose: a pilot review: impact of computer software modifications on compliance. P T. 2008;33:158-165.
15. Braun V, Clarke V. Using thematic analysis in psychology. Qual Research Psych. 2006;3:77-101.
16. Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Gap analysis and key messages for the prescribing and use of blood glucose test strips for the self-monitoring of blood glucose. COMPUS. 2009;3(7):1-13. http://www.cadth.ca/index.php/en/compus/ blood-glucose/reports. Accessed January 25, 2011.
17. Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Optimal therapy recommendations for the prescribing and use of blood glucose test strips. COMPUS. 2009;3(6):1-7. http:// www.cadth.ca/index.php/en/compus/blood-glucose/reports
18. Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. Brussels, Belgium: International Diabetes Federation; 2010. http://www. idf.org/webdata/docs/SMBG_EN2.pdf. Accessed January 25, 2011.
19. Gomes T, Juurlink DN, Shah BR, et al. Blood glucose test strips: options to reduce usage. CMAJ. 2010;182:35-38.
20. Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Current practice analysis of health care providers and patients on self-monitoring of blood glucose. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2009. http://www. cadth.ca/media/pdf/compus_Current_Practice_Report_Vol-3-Issue-5. pdf. Accessed January 25, 2011. COMPUS. 2009;3(5):1-56.
21. Hearnshaw H, Whitlock S, Dale J. Monitoring glucose in blood or urine in type 2 diabetes: current practice. Int J Clin Pract. 2003;5:108-114.
22. Lawler FH, Viviani N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract. 1997;44:369-373.
23. Abbott S, Burns J, Gleadell A, et al. Community nurses and selfmanagement of blood glucose. Br J Community Nurs. 2007;12:6-11.